CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 80 enrolled
Drug / intervention
12 hours interval +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04160221
NCT04160221N/ACompleted
CompareCT.gov

Second Trimester Medical Abortion- New Strategies

Sheba Medical Center·interventional·Posted Nov 12, 2019·Updated Nov 14, 2024

In Brief

A clinical study evaluating 12 hours interval and 24 hours interval for Medical Abortion, Complete or Unspecified, Without Complication. Completed, enrolled 80 participants across 1 site.

Detailed Summary

The use of Mifepristone, an antiprogesterone, and Misoprostol together, has been shown to make the medial abortion process more efficient and reduce the induction-to-abortion interval by almost 50%. Despite the recommended 24-48 Mifepristone-Misoprostol interval, recent retrospective study of a flexible interval, have revealed shorter total abortion time with shorter intervals. In this study we aim to compare 24 to 12 hours Mifepristone to Misoprostol intervals

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMedical Abortion, Complete or Unspecified, Without Complication
CountriesIsrael
CollaboratorsStanford University

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedNov 12, 2019
Enrollment StartNov 1, 2019
Primary CompletionOct 1, 2024
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 6.6 years ago

Interventions

12 hours intervalother

Time interval between treatments

24 hours intervalother

Time interval between treatments